What You Should Know: - Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. - DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: - Cardiopulmonary digital health company Eko raises $65M
in Series C funding to close the gap between virtual and in-person heart and
lung care. - The latest round of funding will enable Eko to expand
in-clinic use of its platform of telehealth and AI algorithms for disease
screening and to launch a monitoring program for cardiopulmonary patients at
home. Eko, a
cardiopulmonary digital
health company,
today announced $65 million in Series C funding led by
Read More
3M and Eko Launches 3M Littmann® CORE Digital Stethoscope for Clinicians
What You Should Know: - 3M and Eko team up to launch 3M Littmann® CORE Digital
Stethoscope to deliver a game-changing tool for clinicians as they assess,
diagnose, and monitor their patients. - The new 3M Littmann CORE Digital Stethoscope offers
clinicians access to both analog and digital auscultation options and connects
to Eko’s software and AI algorithms* to help clinicians better interpret sounds
and detect heart murmurs. 3M™ Littmann® Stethoscopes and Eko, today announced the
Read More
Eko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: Eko launches first AI-Powered telehealth platform for virtual
pulmonary and cardiac exams, providing clinicians with in-person level exam capabilities
during video visits. Already deployed by more than 200 health systems for telehealth, platform goes beyond standard video conferencing to facilitate stethoscope audio, ECG live-streaming, and FDA-cleared identification of atrial fibrillation (AFib) and heart murmurs. Eko today
announced Eko Telehealth, an
Read More
FDA Clears Eko’s AFib, Heart Murmur Detection Algorithms for AI-Powered Stethoscope
- StartX company, Eko, announced today that the FDA has cleared Eko’s AFib and heart murmur detection algorithms, making it the first AI-powered stethoscope to screen for serious heart conditions. - Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool. Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease,
Read More
FDA Breakthrough Status Granted for Heart Failure Algorithm by Eko
- Eko announced the FDA has granted “breakthrough status” for an algorithm that could provide an easily accessible screening test for heart failure during routine physical exams.- This designation is awarded to novel innovations that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases. - Heart failure is often left untreated until it’s too late due to costs, inaccessibility to echocardiogram testing, or misdiagnosis. With nearly six
Read More
Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment
- Eko unveils the second generation of CORE products, which includes a smart stethoscope and a stethoscope attachment designed to make any existing stethoscope smarter.- The technological advancements of the CORE include active noise cancellation, sleeker design, and powerful software to allow medical professionals to more effectively screen for heart disease.- The CORE Digital Attachment ($199) and the fully assembled CORE Digital Stethoscope ($249) are available for pre-order now to healthcare
Read More
Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope, Mayo Clinic and Eko Finds
- Eko and Mayo Clinic announced they have proven that heart failure is detectable during routine physical exams, further validating the Eko DUO digital stethoscopes as a heart failure screening tool. - Today’s news marks the first time that a point of care device with a single lead ECG combined with an AI algorithm identified low ejection fraction in patients.- The results of these findings, which are comparable to research published earlier this year in NatureMedicine, were presented over the
Read More
Eko Raises $20M to Expand Machine Learning Platform for Cardiac Monitoring/Analysis
- AI-driven digital health startup Eko raises $20M led by ARTIS Ventures with participation from 3M and Mayo Clinic. - Funding will be used to accelerate research and development (R&D) and commercialization of Eko’s machine learning platform for cardiac screening/analysis. - Eko’s cardiac monitor combines digital stethoscope and ECG technology both for in-clinic and at-home monitoring, which enables patients to seamlessly and consistently send cardiac data to their
Read More
M3DICINE Launches World’s First FDA-Cleared AI-Enabled Stethoscope System
M3DICINE Inc, designers of intelligent medical devices has announced the launch of Stethee, the world’s first AI enabled stethoscope system. With a revolutionary new design that works as easily as a traditional stethoscope, the Stethee family of products allows users to listen to heart and lungs sounds with sophisticated amplification and filtering technology and to instantly capture and analyze heart and lung sounds and data via Bluetooth to the Stethee iOS or Android App providing a whole new
Read More
